There is a challenge related to prostate and many other cancers that cancer cells form resistance to treatments as the disease progresses. However, these resistance mechanisms are not yet fully ...

"[Tarlatamab] is super interesting, because small cell lung cancer is one of the coldest tumors ... but early results are encouraging. Treating advanced bladder cancer upfront with a nectin-4 ADC and ...

From combining treatments in unprecedented ways to deploying artificial intelligence for personalized medicine, a raft of new ...

AstraZeneca’s Imfinzi recently became the first PD-1/L1 inhibitor to deliver a patient survival win in muscle-invasive ...